The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMicrosaic Regulatory News (MSYS)

Share Price Information for Microsaic (MSYS)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1.05
Bid: 1.00
Ask: 1.10
Change: 0.00 (0.00%)
Spread: 0.10 (10.00%)
Open: 1.05
High: 1.05
Low: 1.05
Prev. Close: 1.05
MSYS Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Appointment of Finance Director

15 Apr 2014 09:17

RNS Number : 8488E
Microsaic Systems plc
15 April 2014
 



Microsaic Systems plc

("Microsaic" or the "Company")

 

Appointment of Andrew Darby as Finance Director

 

15 April 2014: Microsaic Systems plc (AIM: MSYS), the developer of miniaturised chip-based scientific instruments, is delighted to announce the appointment of Andrew Darby as Finance Director. Andrew will replace Malcolm Bateman who is stepping down from the Company and Board after eight years with the Company to focus on a portfolio of other business and charitable interests. Malcolm will continue as consultant to Microsaic for a short period to ensure an orderly transition. Andrew is due to be appointed to the Board of Microsaic on 16 April 2014.

 

Andrew Darby, aged 51, has over 17 years of experience in senior finance, strategic and operational roles within quoted companies in the information technology sector. He joins Microsaic from Active Risk Group plc, a former AIM-listed company specialising in enterprise risk management software solutions, where he spent seven years as Chief Operations Officer and Chief Financial Officer until its successful sale to Sword Group SE in August 2013. Prior to joining Active Risk, Andrew held several senior finance and operational positions with Misys plc, a FTSE250 banking and capital markets software firm, most recently as Finance Director, Banking Division Business Units. Prior to Misys, Andrew was Financial Controller for Generali SpA, the global financial services firm. He qualified as a Chartered Accountant with Coopers & Lybrand (now PriceWaterhouseCoopers) in 1990 and graduated with an MA (Hons) in Classics from the University of Cambridge.

 

Commenting on the appointment, Colin Jump, Chief Executive of Microsaic Systems plc, said:

 

"I am delighted to welcome Andrew to the Company as our new Finance Director. Andrew brings valuable and relevant experience to Microsaic from many years working in senior positions at fast-growing companies that are leaders in their field. His experience with quoted companies will also be important as the Company grows and looks to enhance its relationships with investors and analysts. I am confident that Andrew will make a great contribution to Microsaic in the exciting years ahead. I would also like to thank Malcolm Bateman for his work and dedication to the Company over the last eight years and wish him well with his future career."

 

Andrew Darby added:

 

"I am excited to be joining Microsaic at this time in its development and to have the opportunity to help drive this innovative business forward. Microsaic has a unique proposition in the analytical instrumentation sector and is well positioned to capitalise on the potential of its revolutionary miniaturised mass-spec technology. I look forward to contributing to the translation of this potential into real value for our shareholders."

 

It is anticipated that the preliminary results for the year ended 31 December 2013 will be released on 30 April 2014.

 

The following information is required to be disclosed pursuant to paragraph (g) of Schedule 2 of the AIM Rules for Companies:

 

Current Directorships:

 

None

 

Past Directorships in the last five years:

 

Active Risk Group plc

Active Risk Ltd

Active Risk Inc

Active Risk Pty Ltd

Line International Ltd

 

 

Contacts

 

Microsaic Systems

Colin Jump, CEO

Via Citigate Dewe Rogerson

 

Numis Securities Limited

Stuart Skinner (Nominated Adviser)

James Serjeant (Broker)

 

+44 (0)20 7260 1000

 

Citigate Dewe Rogerson (Financial PR)

Mark Swallow, Malcolm Robertson, Chris Gardner

 

+44 (0)20 7282 2948/2867/2995

 

 

Conscience Creative (Trade PR)

Reita Smith

 

+44 (0)20 3475 4226

 

About Microsaic Systems

 

Microsaic Systems develops and sells chip-based scientific instruments for the chemical identification of substances. The Company's products are based on the 'gold-standard' scientific technique of mass spectrometry.

 

Microsaic Systems has developed a miniaturised mass spectrometer based on its patented, chip-based technologies (ionchip®, spraychip® and vac-chip™), that is smaller, lighter, quieter, more energy efficient and cheaper to run than conventional mass spectrometer systems.

 

Mass spectrometry is used across many industry sectors, including government, energy, utilities, pharmaceutical, diagnostics and healthcare, environmental, food and drink, security and defence, and industrial chemicals - a combined market of $3 billion in 2012.

 

Microsaic Systems was established in 2001 by a team including founders from Imperial College London, and was admitted to AIM in April 2011 under the symbol MSYS.

 

www.microsaic.com

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BOAGGUUUCUPCURA
Date   Source Headline
15th Mar 20227:00 amRNSBoard Appointment and Strategic Update
8th Mar 20224:35 pmRNSPrice Monitoring Extension
7th Mar 20222:05 pmRNSSecond Price Monitoring Extn
7th Mar 20222:00 pmRNSPrice Monitoring Extension
21st Feb 20221:31 pmRNSHolding(s) in Company
17th Feb 20222:45 pmRNSHolding(s) in Company
16th Feb 202211:06 amRNSSecond Price Monitoring Extn
16th Feb 202211:00 amRNSPrice Monitoring Extension
14th Feb 20227:00 amRNSDirector Dealing, Issue of Equity and TVR
28th Jan 20227:00 amRNSResignation of Chief Executive Officer
12th Jan 20224:43 pmRNSHolding(s) in Company
10th Jan 20223:30 pmRNSInvestor Presentation
10th Jan 20227:00 amRNSTrading Update
7th Jan 20222:06 pmRNSSecond Price Monitoring Extn
7th Jan 20222:00 pmRNSPrice Monitoring Extension
13th Dec 20217:00 amRNSFurther order from DeepVerge
12th Nov 20217:00 amRNSNew compact screening platform
5th Nov 202110:12 amRNSHolding(s) in Company
27th Oct 20217:00 amRNSLaunch of technology for scaling drug manufacture
22nd Oct 20217:00 amRNSBoard Change
21st Oct 20217:00 amRNSUpdate on DeepVerge Collaboration
28th Sep 20214:30 pmRNSHolding(s) in Company
27th Sep 20217:00 amRNSInterim Results
24th Sep 20217:00 amRNSSigning of agreement to support China operations
22nd Sep 202111:06 amRNSNotice of Results and Investor Presentation
27th Aug 20214:40 pmRNSSecond Price Monitoring Extn
27th Aug 20214:35 pmRNSPrice Monitoring Extension
23rd Aug 20217:00 amRNSDeepVerge Collaboration for Water & Soil Analysis
9th Aug 20217:00 amRNSHeads of Terms signed with manufacturer in China
6th Jul 202111:55 amRNSInvestor Presentation
6th Jul 20217:00 amRNSTrading update for H1 2021
5th Jul 20219:50 amRNSHolding(s) in Company
2nd Jul 20217:00 amRNSDevelopment of real-time monitoring solution
17th Jun 202110:54 amRNSResult of Annual General Meeting
4th Jun 20217:00 amRNSPre-Annual General Meeting Q&A
25th May 20217:00 amRNSDevelopment of PFAS detection platform
20th May 20217:00 amRNSPosting of Annual Report and Notice of AGM
4th May 20219:00 amRNSPrice Monitoring Extension
4th May 20217:01 amRNSHeads of Terms signed for Chinese market
4th May 20217:00 amRNSFinal Results
28th Apr 20217:00 amRNSNotice of Results and Investor Presentation
31st Mar 20214:41 pmRNSSecond Price Monitoring Extn
31st Mar 20214:36 pmRNSPrice Monitoring Extension
24th Mar 20217:00 amRNSFramework Services Agreement Update
9th Mar 20212:52 pmRNSHolding(s) in Company
9th Mar 20212:06 pmRNSSecond Price Monitoring Extn
9th Mar 20212:01 pmRNSPrice Monitoring Extension
4th Mar 20217:00 amRNSHolding(s) in Company
3rd Mar 20214:41 pmRNSSecond Price Monitoring Extn
3rd Mar 20214:36 pmRNSPrice Monitoring Extension

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.